Top Stock Picks from Analysts

Risultati

16

1 nuovo

Companies which are more than 50% undervalued based on analyst price target.

16 aziende

	Azienda	Ultimo prezzo	Ritorno 7D	Ritorno a 1 anno	Cap. di mercato	Obiettivo degli analisti	Valutazione	Crescita	Rendimento del dividendo	Industria
	HUBN Nuovo	CHF 170.00	1.1%	42.9%	CHF 3.1b	CHF 261.50	43.1	39.4%	1.2%	Capital Goods
	NEAG	CHF 30.90	2.0%	-3.7%	CHF 1.0b	CHF 60.00	6.7	-14.1%	2.9%	Utilities
	CMHC	CHF 57.10	-1.9%	-8.5%	CHF 974.7m	CHF 122.57	10.2	55.1%	3.5%	Pharmaceuticals & Biotech
	KURN	CHF 21.24	-6.0%	-16.0%	CHF 842.6m	CHF 33.92	117.5	58.6%	n/a	Pharmaceuticals & Biotech
	MEDX	CHF 8.91	-0.9%	-16.7%	CHF 362.7m	CHF 14.97	3626.9	64.6%	1.1%	Healthcare
	MIKN	CHF 16.20	0.6%	-12.4%	CHF 275.3m	CHF 29.80	9.6	-1.0%	3.7%	Capital Goods
	PEAN	CHF 4.89	6.4%	-27.6%	CHF 254.8m	CHF 7.87	2.0	104.4%	0%	Real Estate Management and Development
	NWRN	CHF 12.22	-5.7%	37.6%	CHF 254.2m	CHF 47.48	14.2	50.2%	n/a	Pharmaceuticals & Biotech
	SANN	CHF 15.56	-5.8%	12.4%	CHF 238.8m	CHF 27.50	3.1	18.6%	n/a	Pharmaceuticals & Biotech
	BIOV	CHF 24.70	-2.0%	-10.8%	CHF 148.4m	CHF 58.26	45.6	-14.2%	n/a	Pharmaceuticals & Biotech
	MOLN	CHF 3.75	7.4%	25.4%	CHF 137.9m	CHF 9.00	2.5	4.9%	n/a	Pharmaceuticals & Biotech
	VARN	CHF 13.35	1.1%	-31.9%	CHF 134.7m	CHF 25.18	1.5	7.0%	0%	Real Estate Management and Development
	LMN	CHF 11.95	0%	-20.9%	CHF 126.8m	CHF 19.37	41.0	60.9%	3.2%	Consumer Services
	XLS	CHF 13.80	-8.6%	-33.0%	CHF 82.1m	CHF 31.00	285.8	-6.9%	n/a	Pharmaceuticals & Biotech
	MMTX	CHF 0.18	-4.8%	n/a	CHF 23.8m	CHF 2.73	42.9	87.7%	n/a	Pharmaceuticals & Biotech
	ASWN	CHF 0.61	5.2%	-41.3%	CHF 8.7m	CHF 2.00	0.6	83.7%	n/a	Media

Page 1 of 1